415 is a San Francisco based venture capital firm founded in 2013 by Owen Van Natta and Grace Stanat. They provide seed stage funding and advice in the areas of strategy, funding, deals and partnerships, social, e- and m-commerce, operations, acquisition and engagement, culture and growth.
Their exits include talech, Vessel and Spiral Genetics.
Artificial intelligence to help perform visual tasks with more speed, accuracy, and scale
Prellis Biologics is developing technology to build transplantable human organs and tissues.